| Literature DB >> 32765608 |
Mekuria Edae1, Zelalem Teklemariam2, Fitsum Weldegebreal2, Degu Abate2.
Abstract
BACKGROUND: Asymptomatic bacteriuria is one of the major risk factors for the development of urinary tract infections during pregnancy which accounts for about 70% of the cases. However, there is no guideline which recommends routine screening of pregnant women for asymptomatic bacteriuria in most of developing countries including Ethiopia. Thus, the aim of this study was to determine the magnitude, associated factors, and antimicrobial susceptibility pattern of asymptomatic bacteriuria among pregnant women.Entities:
Year: 2020 PMID: 32765608 PMCID: PMC7387989 DOI: 10.1155/2020/1763931
Source DB: PubMed Journal: Int J Microbiol
Sociodemographic characteristics of pregnant women attending at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2019 (n = 281).
| Characteristics | Frequency number (%) |
|---|---|
|
| |
| 18–26 | 157 (55.9) |
| 27–34 | 107 (38.1) |
| 35–44 | 17 (6.0) |
|
| |
|
| |
| Married | 258 (91.8) |
| Divorced | 20 (7.1) |
| Single | 1 (0.4) |
| Widowed | 2 (0.7) |
|
| |
|
| |
| Urban | 126 (44.8) |
| Rural | 155 (55.2) |
|
| |
|
| |
| <1000 | 90 (32) |
| 1000–1999 | 50 (17.8) |
| 2000–2999 | 72 (25.6) |
| >2999 | 69 (24.6) |
|
| |
|
| |
| Orthodox | 56 (19.9) |
| Protestant | 32 (11.4) |
| Muslim | 190 (67.6) |
| Others | 3 (1.1) |
|
| |
|
| |
| Do not read and write | 78 (27.8) |
| Primary (1–8 grade) school | 112 (39.9) |
| Secondary (9–12 grade) school | 45 (16.0) |
| College and above | 46 (16.4) |
|
| |
|
| |
| Student | 8 (2.8) |
| House wife | 181 (64.4) |
| Merchant | 41 (14.6) |
| Civil servant | 49 (17.4) |
| Others | 2 (0.7) |
Pregnancy, Clinical condition, and behavior-related factors of pregnant women attending at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2019 (n = 281).
| Characteristics | Frequency (%) |
|---|---|
|
| |
| Nulligravida | 69 (24.6) |
| Primigravida | 96 (34.2) |
| Multigravida | 58 (20.6) |
| Grand multigravida | 58 (20.6) |
|
| |
|
| |
| First trimester | 43 (15.3) |
| Second trimester | 123 (43.8) |
| Third trimester | 115 (41.0) |
|
| |
|
| |
| First visit | 65 (23.1) |
| Second visit | 151 (53.7) |
| Third visit | 35 (12.5) |
| Fourth visit | 30 (10.7) |
|
| |
|
| |
| Yes | 105 (37.5) |
| No | 176 (62.7) |
|
| |
|
| |
| Yes | 72 (25.6) |
| No | 209 (74.4) |
|
| |
|
| |
| Yes | 24 (8.5) |
| No | 257 (91.5) |
|
| |
|
| |
| Yes | 16 (5.7) |
| No | 265 (94.3) |
|
| |
|
| |
| Anemic | 193 (68.7) |
| Nonanemic | 88 (31.3) |
|
| |
|
| |
| Yes | 50 (17.8) |
| No | 231 (82.2) |
|
| |
|
| |
| Yes | 65 (23.1) |
| No | 216 (76.9) |
|
| |
|
| |
| Yes | 165 (58.4) |
| No | 116 (41.3) |
|
| |
|
| |
| Backward | 169 (60.1) |
| Forward | 112 (39.9) |
|
| |
|
| |
| <2 times | 228 (81.1) |
| >2 times | 53 (18.9) |
Pregnancy-related and personal factors associated with ASB among pregnant women participated in the study at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2019 (n = 281).
| Characteristics | Significant bacteriuria no. (%) | Nonsignificant bacteriuria no. (%) | Crude odds ratio (95% CI) |
| Adjusted odds ratio (95% CI) |
|---|---|---|---|---|---|
|
| |||||
| Nulligravida | 14 (25.0) | 55 (24.2) | 1 | ||
| Primigravida | 18 (32.1) | 78 (34.8) | 1.025 (0.432, 2.434) | 0.805 | |
| Multigravida | 12 (21.4) | 46 (20.4) | 1.130 (0.500, 2.557) | 0.956 | |
| Grand multigravida | 12 (21.4) | 46 (20.4) | 1.000 (0.407, 2.456) | 0.956 | |
|
| |||||
|
| |||||
| First trimester | 10 (17.9) | 36 (15.9) | 1 | ||
| Second trimester | 23 (41.1) | 102 (44.9) | 1.186 (0.510, 2.754) | 0.520 | |
| Third trimester | 23 (41.1) | 89 (39.2) | 1.99 (0.661, 1.506) | 0.692 | |
|
| |||||
|
| |||||
| Anemic | 40 (71.4) | 153 (68.0) | 1.185 (0.623, 2.255) | 0.621 | |
| Nonanemic | 16 (28.6) | 72 (32.0) | 1 | ||
|
| |||||
|
| |||||
| 0–2 | 43 (76.8) | 185 (82.2) | 1 | ||
| ≥2 | 13 (23.2) | 40 (17.8) | 0.715 (0.352, 1.452) | 0.354 | |
|
| |||||
|
| |||||
| Yes | 7(12.5) | 17 (7.5) | 0.929 (0.296, 2.915) | 0.899 | |
| No | 49 (87.5) | 208 (92.4) | 1 | ||
|
| |||||
|
| |||||
| Yes | 6 (10.7) | 10 (6.3) | 1.187 (0.387, 3.640) | 0.764 | |
| No | 50 (89.3) | 215 (93.7) | 1 | ||
|
| |||||
|
| |||||
| 1st visit | 16 (28.6) | 49 (21.8) | 1 | ||
| 4th visit | 6 (10.7) | 24 (10.7) | 0.766 (0.266, 2.205) | 0.744 | |
|
| |||||
|
| |||||
| No | 90 (51.8) | 29 (39.6) | 0.642 (0.357, 1.157) | 0.24 | 1.277 (0.666, 2.447) |
| Yes | 27 (48.2) | 137 (60.4) | 1 | 1 | |
|
| |||||
|
| |||||
| Yes | 15 (26.8) | 57 (25.1) | 0.927 (0.478, 1.800) | 0.824 | |
| No | 41 (73.2) | 168 (74.9) | 1 | ||
|
| |||||
|
| |||||
| Yes | 19 (38) | 31 (62) | 3.214 (1.643, 6.284) | 0.001 | 3.122 (1.378, 7.072) |
| No | 37 (16.1) | 194 (83.9) | 1 | 1 | |
|
| |||||
|
| |||||
| Yes | 29 (51.8) | 76 (33.8) | 1 | ||
| No | 27 (37.5) | 149 (66.2) | 0.478 [0.26, 0.864] | 0.181 | 1.424 (0.719, 2.820) |
|
| |||||
|
| |||||
| Yes | 6 (10.7) | 59 (26.0) | 1 | ||
| No | 50 (89.3) | 168 (74.0) | 2.962 (1.207, 7.266) | 0.018 | 3.160 (1.173, 6.514) |
|
| |||||
|
| |||||
| Forward | 34 (60.7) | 79 (34.8) | 2.913 (1.595, 5.320) | 0.001 | 2.853 (1.255, 4.320) |
| Backward | 22(39.3) | 148 (65.2) | 1 | ||
CI, confidence interval; p < 0.25; p value <0.05; OR: odds ratio.
Antimicrobial susceptibility pattern of Gram-negative bacteria isolated from urine culture of pregnant women with asymptomatic bacteriuria at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2019.
| Isolates | Number | Pattern | AMP | AUG | A | CN | COT | CD | T | CRO | E |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 25 |
|
|
|
|
|
|
|
|
| |
| S | — | 15 (60.0) | 13 (52.0) | 17 (68.0) | 14 (56.0) | 9 (36.0) | 10 (40.0) | 23 (92.0) | 13 (52.0) | ||
| I | 5 (20.0) | 4 (16.0) | 3 (12.0) | 4 (16.0) | 3 (12.0) | 4 (16.0) | 5 (20.0) | 1 (4.0) | 4 (16.0) | ||
| R | 20 (80.0) | 6 (24.0) | 9 (36.0) | 4 (16.0) | 8 (32.0) | 12 (48.0) | 10 (40.0) | 1 (4.0) | 7 (28.0) | ||
|
| |||||||||||
|
| 5 | ||||||||||
| S | 1 (20) | 4 (80) | 2 (40) | 3 (60) | 3 (60) | 2 (40) | 2 (40) | 3 (60) | — | ||
| I | 3 (60) | — | — | 2 (40) | 2 (40) | — | 1 (20) | 2 (40) | 1 (20) | ||
| R | 1 (20) | 1 (20) | 3 (60) | — | — | 3 (60) | 2 (40) | — | 4 (80) | ||
|
| |||||||||||
|
| 2 | S | 1 (50) | 1 (50) | 1 (50) | 2 (100) | — | 1 (50) | 1 (50) | 2 (100) | — |
| I | — | — | — | — | 2 (100) | 1 (50) | — | — | 1 (50) | ||
| R | 1 (50) | 1 (50) | 1 (50) | — | — | — | 1 (50) | — | 1 (50) | ||
|
| |||||||||||
|
| 2 | ||||||||||
| S | — | 2 (100) | 2 (100) | 1 (50) | — | — | — | 2 (100) | 1 (50) | ||
| I | — | — | — | — | — | — | — | — | — | ||
| R | 2 (100) | 1 (50) | 2 (100) | 2 (100) | 2 (100) | — | 1 (50) | ||||
|
| |||||||||||
| Total | 34 | ||||||||||
| S | 2 (5.8) | 22 (64.7) | 18 (52.9) | 23 (67.5) | 17 (50.0) | 12 (35.3) | 13 (38.2) | 30 (88.2) | 15 (44.0) | ||
| I | 8 (23.5) | 4 (11.8) | 3 (8.8) | 6 (17.8) | 7 (20.5) | 5 (14.7) | 6 (17.8) | 3 (8.8) | 6 (17.8) | ||
| R | 24 (70.5) | 8 (23.5) | 13 (38.2) | 5 (14.7) | 10 (29.4) | 17 (50.0) | 15 (44.0) | 1 (3.0) | 13 (38.2) | ||
AMP, Ampicillin; CRO, Ceftriaxone; A, Amoxicillin; CN, Gentamicin; COT, Cotrimoxazole; AUG, Augmentin; ERY, Erythromycin; CD, Clindamycin; T, Tetracycline; CoNS, coagulase-negative staphylococci species; S, sensitive; I, intermediate; R, resistant.